Liver regeneration–associated hepatocellular YAP1 activation prevents colorectal cancer liver metastasis through glutamine competition
Science Advances · 2025
DOI: 10.1126/sciadv.adw6926 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Qiang Yu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcin…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, Glutamine, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The literature suggests that hepatocellular Yes-associated protein 1 (YAP1) signaling is activated following hepatectomy and that such activation can suppress the growth of metastatic liver tumors. The prognosis of a real-world cohort of 240 patients with colorectal cancer liver metastasis (CRLM) undergoing major and minor hepatectomy was compared after adjusting for confounding factors. To model CRLM, we induced liver metastasis in mice by transsplenically injecting MC38 cells. We found that patients with CRLM and mice undergoing major hepatectomy had better survival compared to those undergoing minor hepatectomy. Mechanistically, extensive hepatectomy activates hepatocellular YAP1 by regulating the epidermal growth factor receptor, altering glutamine metabolism–related gene expression and increasing liver glutamine consumption. This metabolic shift leads to glutamine scarcity in tumor cells, causing increased reactive oxygen species production, which promotes loss of YAP1 activity in tumor cells. Consequently, the production of the chemokine CXCL5 is suppressed, which inhibits myeloid-derived suppressor cell infiltration and enhancing the immunological function of CD8 + T cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032,…
- Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
- Graduate Institute of Biomedical Sciences, Research Center for Cancer Biology, and Center for Molecular Medicine, China Medical University, Taichung 404, Taiwan.
- Department of Liver Surgery, Zhongshan Hospital (Xiamen Branch), Fudan University, Xiamen 361015, P.R. China.
ORCID-Profile: Qiang Yu, Mincheng Yu, Peiyi Xie, Lei Guo, Yufei Zhao, Jian Zhou, Jia Fan, Mien-Chie Hung, Yongfeng Xu, Bo Zhang, Qinghai Ye, Hui Li
Zitieren
APA
Yu, Q., Yu, M., Xie, P., Guo, L., Zhao, Y., Xu, W., Li, X., Wu, M., Zhang, Z., Chen, Z., Xiao, Y., Zhou, J., Fan, J., Hung, M. C., Xu, Y., Zhang, B., Ye, Q., & Li, H. (2025). Liver regeneration–associated hepatocellular YAP1 activation prevents colorectal cancer liver metastasis through glutamine competition. Science Advances. https://doi.org/10.1126/sciadv.adw6926
Vancouver
Yu Q, Yu M, Xie P, Guo L, Zhao Y, Xu W, et al. Liver regeneration–associated hepatocellular YAP1 activation prevents colorectal cancer liver metastasis through glutamine competition. Science Advances. 2025. doi:10.1126/sciadv.adw6926
BibTeX
@article{Yu2025,
author = {Yu, Qiang and Yu, Mincheng and Xie, Peiyi and Guo, Lei and Zhao, Yufei and Xu, Wenxin and Li, Xian and Wu, Mengyuan and Zhang, Zihao and Chen, Zheng and Xiao, Yongsheng and Zhou, Jian and Fan, Jia and Hung, Mien-Chie and Xu, Yongfeng and Zhang, Bo and Ye, Qinghai and Li, Hui},
title = {Liver regeneration–associated hepatocellular YAP1 activation prevents colorectal cancer liver metastasis through glutamine competition},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adw6926}
}
EUVIMED